Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using Spectral Domain Optical Coherence Tomography

Wu, Huijuan MD, PhD*,†; de Boer, Johannes F. PhD; Chen, Teresa C. MD*

doi: 10.1097/IJG.0b013e3181f3eb64
Original Studies
Buy

Purpose To evaluate the reproducibility of the peripapillary retinal nerve fiber layer (RNFL) thickness measurements obtained by Spectralis spectral domain optical coherence tomography (OCT) (Heidelberg Engineering, Heidelberg, Germany) in normal and glaucoma participants.

Methods Participants were recruited from a university-based clinic. Peripapillary RNFL thickness measurements were repeated 3 times during the same visit using the follow-up function. One eye of each participant was randomly selected for statistical analysis. Reproducibility was evaluated using within-subject standard deviation (Sw), coefficient of variation (CV), and intraclass correlation coefficient (ICC). Spearman rank correlation coefficient analyses were used to assess the correlation of the standard deviation of the 3 measurements for each participant with the RNFL thickness value.

Results Forty-five normal participants and 33 glaucoma patients were included in the study. The CVs ranged from 1.45% [overall global (G)] to 2.59% [temporal quadrant (T)] in normal eyes and from 1.74% (G) to 3.22% (T) in the glaucomatous eyes. ICCs ranged from 0.977 (T) to 0.990 (G and inferior-nasal sector) in normal eyes and from 0.983 (T) to 0.997 (inferior quadrant) in glaucomatous eyes. Sw were from 1.34 μm (G) to 2.39 μm (superior-temporal and inferior-temporal sectors) in normal eyes and from 1.14 μm (G) to 2.25 μm (superior-nasal sector) in the glaucomatous eyes. There were no significant correlations between RNFL thickness values and the measurement variability for each participant.

Conclusions Spectralis OCT shows excellent reproducibility for measuring the peripapillary RNFL thickness values in both healthy and glaucoma participants.

*Glaucoma Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA

Department of Ophthalmology, Peking University, People's Hospital, Beijing, China

Department of Physics and Astronomy, VU University, Amsterdam, The Netherlands

Supported in part by the National Institutes of Health (R01 EY14975-01).

Disclosure: The authors declare no conflict of interest.

Reprints: Teresa C. Chen, MD, Massachusetts Eye and Ear Infirmary, Glaucoma Service, 243 Charles Street, Boston, MA, 02114 (e-mail: teresa_chen@meei.harvard.edu).

Received February 19, 2010

Accepted July 18, 2010

© 2011 Lippincott Williams & Wilkins, Inc.